Boston Scientific Corporation
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devic…
Medical - Devices
US, Marlborough [HQ]
FA
Fundamental Analysis · Most Recent Quarter
A dedicated fundamental analysis might help you to get a quick overview
of the
financial stability. It is important to understand the
FA Algorithm
and the criterias before valuing it as a top-tier resource.
1
Financial Health
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Current Ratio | 26.09 | 1.66 | 1.32 | |
| Debt/Assets | n.A. | n.A. | n.A. | |
| Debt/Equity | n.A. | n.A. | n.A. | |
| Net Debt/EBITDA | 2.03 | 8.66 | 8.49 | |
| Naive Interpretation | member | |||
2
Per Share
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Book Value | 3.12 | 13.57 | 13.16 | |
| Cash | 368.26 | 2.76 | 0.59 | |
| Capex | 8.43 | -0.17 | -0.18 | |
| Free Cash Flow | -88.29 | -0.06 | 0.47 | |
| Revenue | 3.30 | 2.63 | 2.54 | |
| Naive Interpretation | member | |||
3
Profitability
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Gross Margin | -0.81 | 0.69 | 0.69 | |
| Operating Margin | 14.63 | 0.18 | 0.16 | |
| ROA | -6.65 | 0.01 | 0.01 | |
| ROE | -5.72 | 0.02 | 0.03 | |
| ROIC | -10.30 | 0.02 | 0.02 | |
| Naive Interpretation | member | |||
4
Valuation
The "Valuation Entry" for the Focus of BSX is permitted for members.
5
Growth
The "Growth Entry" for the Focus of BSX is permitted for members.
6
Leverage & Liquidity